Mechanism of pachymic acid in the treatment of gastric cancer based on network pharmacology and experimental verification

doi:10.4251/wjgo.v16.i1.30

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2522)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

106

WORD

HTML

1301

Figures (1-7)

182

Tables (1-1)

182

Sum=1792

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

128

Download

523

Sum=651

Jan 15, 2024 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Gastrointest Oncol. Jan 15, 2024; 16(1): 30-50
Published online Jan 15, 2024. doi: 10.4251/wjgo.v16.i1.30

Full Size Figure Download Figure

Figure 1 Flow chart. A variety of databases used to find the targets of gastric cancer (GC) and pachymic acid (PA), and the common targets were obtained. The possible targets and pathways of PA in the treatment of GC were analyzed by network pharmacology, and finally verified by experiments.

Citation: Du YH, Zhao JJ, Li X, Huang SC, Ning N, Chen GQ, Yang Y, Nan Y, Yuan L. Mechanism of pachymic acid in the treatment of gastric cancer based on network pharmacology and experimental verification. World J Gastrointest Oncol 2024; 16(1): 30-50
URL: https://www.wjgnet.com/1948-5204/full/v16/i1/30.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i1.30